{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:15Z","timestamp":1760244915171},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1995,11]]},"DOI":"10.1016\/0959-8049(95)00345-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T20:01:24Z","timestamp":1027627284000},"page":"2003-2007","source":"Crossref","is-referenced-by-count":29,"title":["Primary central nervous system lymphoma: Treatment with chemotherapy and radiotherapy"],"prefix":"10.1016","volume":"31","author":[{"given":"M.","family":"Sarazin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Monjour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nibio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Poisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Y.","family":"Delattre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0959-8049(95)00345-2_BIB1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.40.1.80","article-title":"Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy","volume":"40","author":"De Angelis","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/0959-8049(95)00345-2_BIB2","first-page":"95","article-title":"Primary malignant lymphomas of the central nervous system in man","volume":"6","author":"Jellinger","year":"1975","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/0959-8049(95)00345-2_BIB3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M","article-title":"Increasing incidence of primary brain lymphoma in the U.S","volume":"62","author":"Eby","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(81)90060-2","article-title":"Radiation therapy in the management of primary malignant lymphoma of the brain","volume":"7","author":"Berry","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/0959-8049(95)00345-2_BIB5","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/1097-0142(19830601)51:11<2048::AID-CNCR2820511115>3.0.CO;2-T","article-title":"Primary non Hodgkin lymphoma of the central nervous system: results of radiotherapy","volume":"51","author":"Gonzales","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/1097-0142(19910301)67:5<1431::AID-CNCR2820670527>3.0.CO;2-K","article-title":"Primary central nervous system lymphoma as a second malignancy","volume":"67","author":"De Angelis","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","article-title":"Combined modality therapy for primary CNS lymphoma","volume":"10","author":"De Angelis","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00345-2_BIB8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archneur.1990.00530100081017","article-title":"Adjuvant chemotherapy for primary lymphoma of the central nervous system","volume":"47","author":"Chamberlain","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/0959-8049(95)00345-2_BIB9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/1097-0142(19861015)58:8<1609::AID-CNCR2820580805>3.0.CO;2-7","article-title":"Developments in the diagnosis and treatment of primary CNS lymphoma","volume":"58","author":"Neuwelt","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB10","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/1097-0142(19800401)45:7<1556::AID-CNCR2820450707>3.0.CO;2-B","article-title":"Successful treatment of recurrent primary central nervous system lymphoma with high dose methotrexate","volume":"45","author":"Ervin","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.1989.70.2.0190","article-title":"High-dose methrotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases","volume":"70","author":"Gabbai","year":"1989","journal-title":"J Neurosurg"},{"key":"10.1016\/0959-8049(95)00345-2_BIB12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/08880019009034320","article-title":"Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3h intravenous infusion in children with non-Hodgkin's lymphoma","volume":"7","author":"Vassal","year":"1990","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/0959-8049(95)00345-2_BIB13","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/1097-0142(197610)38:4<1476::AID-CNCR2820380405>3.0.CO;2-J","article-title":"Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system","volume":"38","author":"Herbst","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3171\/jns.1985.62.4.0522","article-title":"Primary central nervous system lymphoma","volume":"62","author":"Kawakami","year":"1985","journal-title":"J Neurosurg"},{"key":"10.1016\/0959-8049(95)00345-2_BIB15","first-page":"1039","article-title":"High dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin's lymphomas including CNS involvement","volume":"50","author":"Skarin","year":"1977","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00345-2_BIB16","first-page":"1419","article-title":"Phase II evaluation of thiothepa for treatment of central nervous system tumors","volume":"63","author":"Levin","year":"1989","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(95)00345-2_BIB17","first-page":"1549","article-title":"Treatment of neoplastic meningitis with intraventricular thiothepa and methotrexate","volume":"66","author":"Trump","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(95)00345-2_BIB18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0360-3016(89)90550-6","article-title":"Chemoradiation in brain tumors. Adverse effects","volume":"17","author":"Levin","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/0959-8049(95)00345-2_BIB19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3171\/jns.1988.68.6.0835","article-title":"Primary central nervous system lymphoma","volume":"68","author":"Hochberg","year":"1988","journal-title":"J Neurosurg"},{"key":"10.1016\/0959-8049(95)00345-2_BIB20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","article-title":"Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation therapy oncology group","volume":"23","author":"Nelson","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/0959-8049(95)00345-2_BIB21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P","article-title":"Primary malignant lymphomas of the central nervous system","volume":"34","author":"Henry","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/1097-0142(19930801)72:3<843::AID-CNCR2820720333>3.0.CO;2-#","article-title":"The clinical spectrum of ocular lymphoma","volume":"72","author":"Peterson","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(95)00345-2_BIB23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3171\/jns.1984.61.2.0369","article-title":"Combined malignant lymphoma of the eye and CNS","volume":"61","author":"Rockwood","year":"1984","journal-title":"J Neurosurg"},{"key":"10.1016\/0959-8049(95)00345-2_BIB24","first-page":"1261","article-title":"Leukoencephalopathy following high dose methotrexate chemotherapy with leucovorin rescue","volume":"64","author":"Allen","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(95)00345-2_BIB25","first-page":"89","article-title":"Neurologic sequelae of methotrexate and ionising radiation. A new classification","volume":"65","author":"Bleyer","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(95)00345-2_BIB26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V51.5.835.835","article-title":"Concentration time methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms","volume":"51","author":"Bleyer","year":"1978","journal-title":"Blood"},{"key":"10.1016\/0959-8049(95)00345-2_BIB27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0277-5379(85)90275-5","article-title":"Effect of irradiation on the pharmacokinetics of methotrexate in rats. Alteration of the blood brain barrier","volume":"21","author":"Storm","year":"1985","journal-title":"Eur J Clin Oncol"},{"key":"10.1016\/0959-8049(95)00345-2_BIB28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1097-0142(19890301)63:5<939::AID-CNCR2820630526>3.0.CO;2-V","article-title":"Diagnosis factors in the diagnosis and treatment of primary central nervoussystem lymphoma","volume":"63","author":"Pollack","year":"1989","journal-title":"Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804995003452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804995003452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T22:26:44Z","timestamp":1580336804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0959804995003452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["0959804995003452"],"URL":"https:\/\/doi.org\/10.1016\/0959-8049(95)00345-2","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}